Alexander Nolte - Oct 22, 2021 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Accounting Officer
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Oct 22, 2021
Transactions value $
$0
Form type
3
Date filed
11/4/2021, 04:03 PM
Next filing
Feb 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 62K $21.36 Direct F1
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 35K $19.36 Direct F2
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 5K $18.03 Direct F3
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 2K $9.63 Direct F4
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 16K $9.47 Direct F5
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 11.7K $9.24 Direct F6
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 7K $9.00 Direct F7
holding SNDX Stock Options (Right to buy) Oct 22, 2021 Common Stock 18K $6.38 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2021, subject to the reporting person's continuous service on the relevant vesting dates.
F2 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning September 30, 2021, subject to the reporting person's continuous service on the relevant vesting dates.
F3 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning May 31, 2020, subject to the reporting person's continuous service on the relevant vesting dates.
F4 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2018, subject to the reporting person's continuous service on the relevant vesting dates.
F5 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 29, 2020, subject to the reporting person's continuous service on the relevant vesting dates.
F6 Twenty-five percent (25%) of the total number of shares underlying the option vested on May 1, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
F7 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning July 31, 2019, subject to the reporting person's continuous service on the relevant vesting dates.
F8 One forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, beginning February 28, 2019, subject to the reporting person's continuous service on the relevant vesting dates.